首页> 美国卫生研究院文献>Annals of Vascular Diseases >Influencing Factors for Abdominal Aortic Aneurysm Sac Shrinkage and Enlargement after EVAR: Clinical Reviews before Introduction of Preoperative Coil Embolization
【2h】

Influencing Factors for Abdominal Aortic Aneurysm Sac Shrinkage and Enlargement after EVAR: Clinical Reviews before Introduction of Preoperative Coil Embolization

机译:EVAR后腹主动脉瘤囊缩小和增大的影响因素:术前线圈栓塞术前的临床评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Background: We previously reported effectiveness of coil embolization (CE) to aortic branched vessels before endovascular aortic repair (EVAR) for abdominal aortic aneurysm (AAA) because of significant shrinkage of aneurysmal sac. In this study, we investigated EVAR cases to clarify influential factors of aneurysmal shrinkage and enlargement.Methods: 148 consecutive cases before the introduction of CE were retrospectively reviewed based on the presence of PT2EL (persistent type 2 endoleak) and change in sac diameter after EVAR by multivariate analysis.Results: (A) PT2EL risk factors were patent inferior mesenteric artery (IMA) and thinner mural thrombus inside aneurysmal sac. (B) Sac enlargement risk factors were antiplatelet intake, PT2EL, and female gender. (C) Sac shrinkage predictive factors were the absences of thoracic aortic aneurysm, antiplatelet intake, PT2EL, and coronary artery disease.Conclusion: CE to IMA was considered to be effective because patent IMA and antiplatelet intake were significant risk factors for sac enlargement. So, more meticulous therapeutic strategy, including treatment priority (AAA first or CAD first) and choice of treatment (EVAR vs. AAA) based on anatomical features of AAA was required to improve late outcomes.
机译:背景:我们先前曾报道,由于动脉瘤囊的明显萎缩,在进行腹腔主动脉瘤(AAA)的腔内主动脉修复(EVAR)之前,对主动脉分支血管进行线圈栓塞(CE)的有效性。方法:根据PT2EL(持续性2型内漏)的存在和EVAR术后囊腔直径的变化,回顾性研究EVA病例,以明确影响动脉瘤缩小和扩大的因素。结果:(A)PT2EL的危险因素是肠系膜下动脉未闭(IMA)和动脉瘤囊壁薄壁血栓。 (B)囊肿扩大的危险因素是抗血小板摄入,PT2EL和女性。 (C)囊囊收缩的预测因素是胸主动脉瘤,抗血小板摄入,PT2EL和冠状动脉疾病的缺失。结论:CEA对IMA被认为是有效的,因为IMA专利和抗血小板摄入是囊肿扩大的重要危险因素。因此,需要采取更加细致的治疗策略,包括治疗优先级(AAA优先或CAD优先)和基于AAA解剖特征的治疗选择(EVAR与AAA),以改善晚期疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号